Khalid, “ROLE OF SGLT-2 INHIBITORS (GLIFLOZINS) AND CARDIORENAL OUTCOME IN PATIENTS WITH OR WITHOUT DIABETES”, J Popl Ther Clin Pharmacol, vol. 30, no. 18, pp. 1001–1009, Oct. 2023.